Active control of mucosal tolerance and inflammation by human IgA and IgG antibodies - 05/08/20
Doi : 10.1016/j.jaci.2020.04.032
Willianne Hoepel, MSc a, b, Korneliusz Golebski, PhD c, Cornelis M. van Drunen, PhD d, Jeroen den Dunnen, PhD a, b, ⁎ 
a Department of Rheumatology and Clinical Immunology, Academic Medical Center, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands
b Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands
c Department of Respiratory Medicine, Amsterdam, The Netherlands
d the Department of Otorhinolaryngology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
∗Corresponding author: Jeroen den Dunnen, PhD, Meibergdreef 9, Amsterdam, The Netherlands.The NetherlandsMeibergdreef 9Amsterdam
Key words : Fc receptor, antibodies, inflammation, tolerance, allergy, inflammatory bowel disease, chronic rhinosinusitis, dendritic cells, epithelial cells
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 146 - N° 2
P. 273-275 - août 2020 Retour au numéro
Article précédent
- Targeting maternal immune function during pregnancy for asthma prevention in offspring: Harnessing the “farm effect”?
- Patrick G. Holt, Deborah H. Strickland, Adnan Custovic
- NK cells as a possible new player in atopic dermatitis
- Kenji Kabashima, Stephan Weidinger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?